Academic literature on the topic 'Arginine-glycine-aspartic acid (RGD)'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Arginine-glycine-aspartic acid (RGD).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Arginine-glycine-aspartic acid (RGD)"

1

Xie, Linlin, Xiaomin Zhi, Nao Xiao, Chen-Jie Fang, and Chun-Hua Yan. "Constraining the conformation of peptides with Au nanorods to construct multifunctional therapeutic agents with targeting, imaging, and photothermal abilities." RSC Advances 8, no. 47 (2018): 26517–22. http://dx.doi.org/10.1039/c8ra04379e.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Boonyakiat, Yingmanee, Pamela J. Hughes, Farideh Ghazi, and Glyn Stanway. "Arginine-Glycine-Aspartic Acid Motif Is Critical for Human Parechovirus 1 Entry." Journal of Virology 75, no. 20 (2001): 10000–10004. http://dx.doi.org/10.1128/jvi.75.20.10000-10004.2001.

Full text
Abstract:
ABSTRACT The human parechovirus 1 RGD motif in VP1 was studied by mutagenesis. An RGD-to-RGE change gave only revertant viruses with a restored RGD, while deletion of GD was lethal and nonrevertable. Mutations at the +1 and +2 positions had some effect on growth properties and a +1 M-to-P change was lethal. These studies indicate that the RGD motif plays a critical role in infectivity, presumably by interacting with integrins, and that downstream amino acids can have an influence on function.
APA, Harvard, Vancouver, ISO, and other styles
3

Chong, Beng H. "Drug-induced thrombocytopenia: MIBS trumps LIBS." Blood 119, no. 26 (2012): 6177–78. http://dx.doi.org/10.1182/blood-2012-04-423939.

Full text
Abstract:
Understanding the pathogenesis of drug-induced immune thrombocytopenia is the key to better patient management. In this issue of Blood, Bougie and colleagues provide further useful insights into the mechanism of thrombocytopenia caused by arginine-glycine-aspartic acid (RGD) mimetic drugs.1
APA, Harvard, Vancouver, ISO, and other styles
4

Anderson, Eric H., Mark A. Ruegsegger, Gurunathan Murugesan, Kandice Kottke-Marchant, and Roger E. Marchant. "Extracellular Matrix-Like Surfactant Polymers Containing Arginine-Glycine-Aspartic Acid(RGD) Peptides." Macromolecular Bioscience 4, no. 8 (2004): 766–75. http://dx.doi.org/10.1002/mabi.200300125.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ogle, Roy C., and Charles D. Little. "Collagen binding proteins derived from the embryonic fibroblast cell surface recognize arginine-glycine-aspartic acid." Bioscience Reports 9, no. 3 (1989): 329–40. http://dx.doi.org/10.1007/bf01114685.

Full text
Abstract:
Several cell surface proteins (Mr=120,000, 90,000, 63,000 and 47,000) apparently integral to embryonic fibroblast plasma membranes were extracted with detergent and isolated by collagen affinity chromatography. Certain of these proteins (Mr=120,000, 90,000 and 47,000) were specifically eluted from collagen affinity columns by synthetic peptides containing the amino acid sequence arginyl-glycyl-aspartic acid (RGD). These data show that a number of collagen binding proteins exist on the embryonic fibroblast cell surface. Some of the proteins may be collagen receptors binding to RGD sequences in the collagen molecule while at least one of the proteins (Mr=63,000) recognizes features other than RGD.
APA, Harvard, Vancouver, ISO, and other styles
6

Gonçalves, R. F., D. Erickson, A. D. Ealy, and G. J. Killian. "271INFLUENCE OF ARGININE-GLYCINE-ASPARTIC ACID (RGD) IN BOVINE SPERM-EGG BINDING, AND FERTILIZATION IN VITRO." Reproduction, Fertility and Development 16, no. 2 (2004): 256. http://dx.doi.org/10.1071/rdv16n1ab271.

Full text
Abstract:
Osteopontin (OPN), a secretory RGD-containing phosphoprotein, has been identified in cow oviductal ephitelium and fluid, but its role in fertilization is unclear. RGD peptide is capable of blocking fertilization, inducing intracellular Ca2+ transients, and initiating parthenogenetic development when present during bovine fertilization in vitro.This study was conducted to determine whether in vitro sperm binding to the zona pellucida (ZP) and fertilization of bovine oocytes were affected by treating the sperm or oocytes with RGD (arginine–glycine–aspartic acid, a sequence recognized by integrins) or non-RGD-containing peptides. In vitro matured oocytes were incubated (39°C, 5% CO2 in air) for 2 hours in fertilization medium with: (1) no peptides;; (2) 50μgmL−1 RGD (Calbiochem®, San Diego, CA, USA); (3) 1000μgmL−1; (4) 50μgmL−1 non-RGD (Calbiochem®); (5) 1000μgmL−1 non-RGD. The bovine sperm from two differents bulle was collected by artificial vagina, pooled, washed twice with MTM at 500g for 10min and incubated (39°C, 5% CO2 in air) for two h at 5×107 concentration in MTM with: (6) no peptides;; (7) 50μgmL−1 RGD;; (8) 1000μgmL−1; (9) 50μgmL−1 non-RGD; (10) 1000μgmL−1 non-RGD. Following incubation, treated and untreated oocytes were washed and inseminated with 1×105 treated or untreated fresh spermatozoa per 10 oocytes;; after the sperm were recovered from a Percoll gradient (45%/90%). After 18–20h, oocytes were removed from co-culture, and washed in TL-HEPES. Oocytes used to assess sperm binding were stained with Hoescht 33342, and the number of sperm bound per ZP counted. The remaining oocytes were fixed in acid alcohol, stained with 1% acetato-orcein and observed for the presence of pronuclei. For the five replicates, 100–120 oocytes were used for fertilization and 150–170 oocytes were used for sperm-egg binding assays. Data were analized by SAS. Treatment of sperm or oocytes with the RGD peptide significantly decreased (P<0.05) fertilization compared to the non-treated controls or those treated with non-RGD peptides: (1) 80%±3.0; (2) 42%±3.0; (3) 30.2%±3.0; (4) 78.5%±3.0; (5) 79.1%±3.0; (6) 78.9%±3.0; (7) 41.3%±3.0; (8) 29.1%±3.0; (9) 79.2%±3.0; (10) 80.2%±3.0. More sperm bound to the ZP of untreated or non-RGD-treated oocytes or sperm than those incubated with the RGD peptide: (1) 71.2±4.1; (2) 33.2±4.2; (3) 24.2±4.1; (4) 69.5±4.1; (5) 70.2±4.2; (6) 71.9±4.2; (7) 29.8±4.2; (8) 19.8±4.2; (9) 68.9±4.2; (10) 70.6±4.2. These studies demonstrated that incubation of bovine oocytes or spermatozoa with a RGD peptide inhibits sperm-egg binding and fertilization in vitro. These findings support the notion that the role of osteopontin in bovine fertilization may involve inteaction with integrins via its RGD sequence.
APA, Harvard, Vancouver, ISO, and other styles
7

Fraczyk, Justyna, Joanna Wasko, Malgorzata Walczak, et al. "Conjugates of Copper Alginate with Arginine-Glycine-Aspartic Acid (RGD) for Potential Use in Regenerative Medicine." Materials 13, no. 2 (2020): 337. http://dx.doi.org/10.3390/ma13020337.

Full text
Abstract:
Current restrictions on the use of antibiotics, associated with increases in bacterial resistance, require new solutions, including materials with antibacterial properties. In this study, copper alginate fibers obtained using the classic wet method were used to make nonwovens which were modified with arginine-glycine-aspartic acid (RGD) derivatives. Stable polysaccharide-peptide conjugates formed by coupling with 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium toluene-4-sulfonate (DMT/NMM/TosO−), and materials with physically embedded RGD derivatives, were obtained. The materials were found to be characterized by very high antibacterial activity against S. aureus and K. pneumoniae. Cytotoxicity studies confirmed that the materials are not cytotoxic. Copper alginate conjugates with RGD peptides have strong potential for use in regenerative medicine, due to their biocompatibility and innate antibacterial activity.
APA, Harvard, Vancouver, ISO, and other styles
8

Goligorsky, M. S., H. Kessler, and V. I. Romanov. "Molecular mimicry of integrin ligation: therapeutic potential of arginine-glycine-aspartic acid (RGD) peptides." Nephrology Dialysis Transplantation 13, no. 2 (1998): 254–63. http://dx.doi.org/10.1093/oxfordjournals.ndt.a027815.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Steed, D. L., J. J. Ricotta, J. J. Prendergast, et al. "Promotion and Acceleration of Diabetic Ulcer Healing by Arginine-Glycine-Aspartic Acid (RGD) Peptide Matrix." Diabetes Care 18, no. 1 (1995): 39–46. http://dx.doi.org/10.2337/diacare.18.1.39.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Li, Jing, Chunfu Zhang, Ke Yang, Ping Liu, and Lisa X. Xu. "SPIO–RGD nanoparticles as a molecular targeting probe for imaging tumor angiogenesis using synchrotron radiation." Journal of Synchrotron Radiation 18, no. 4 (2011): 612–16. http://dx.doi.org/10.1107/s090904951101017x.

Full text
Abstract:
Angiogenesis, new blood vessels sprouting from pre-existing vessels, is essential to tumor growth, invasion and metastasis. It can be used as a biomarker for early stage tumor diagnosis and targeted therapy. To visualize angiogenesis many molecular imaging modalities have been used. In this study a novel X-ray molecular targeting probe using superparamagnetic iron oxide (SPIO) conjugated with arginine–glycine–aspartic acid (SPIO–RGD) has been developed. Based on the extremely high sensitivity to the iron element of synchrotron radiation X-ray fluorescence and the superior spatial resolution of third-generation synchrotron radiation, the feasibility of SPIO–RGD as a promising molecular probe for imaging tumor angiogenesis has been demonstrated.
APA, Harvard, Vancouver, ISO, and other styles
More sources
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!